Trial Profile
A phase II trial of coversin in patients with Guillain Barre syndrome (GBS).
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Nomacopan (Primary)
- Indications Guillain-Barre syndrome; Haemolytic uraemic syndrome
- Focus Therapeutic Use
- 21 Jul 2015 New trial record